Medicare Enrolled
Dr. Edit Tolnai, M.D.
Hematology · Jupiter, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tolnai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tolnai? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tolnai
Dr. Edit Tolnai is a hematology in Jupiter, FL, with 20 years in practice. Based on federal Medicare data, Dr. Tolnai performed 24,003 Medicare services across 2,749 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tolnai received a total of $16,969 from 82 pharmaceutical and/or device companies across 1021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tolnai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ 24,003 Medicare services$ $16,969 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,003
Medicare services
Bottom 30% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
2,749
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,200 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 5,700 | $0 | $5 |
| Epoetin alfa injection (Retacrit) for anemia | 5,000 | $6 | $35 |
| Denosumab injection (Prolia/Xgeva) | 3,120 | $19 | $45 |
| Contrast dye for imaging (iodine-based) | 1,800 | $0 | $1 |
| Blood draw (venipuncture) | 1,303 | $8 | $14 |
| Complete blood count (CBC) with differential | 1,207 | $8 | $34 |
| Office visit, established patient (30-39 min) | 904 | $96 | $334 |
| Comprehensive metabolic blood panel | 881 | $10 | $46 |
| Dexamethasone injection (steroid) | 818 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $59 |
| Bilirubin level, direct | 464 | $5 | $22 |
| Lactate dehydrogenase (enzyme) level | 348 | $6 | $26 |
| Drug injection, under skin or into muscle | 237 | $11 | $75 |
| Magnesium level test | 196 | $7 | $29 |
| Administration of chemotherapy into vein, 1 hour or less | 186 | $102 | $477 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 175 | $22 | $107 |
| Carcinoembryonic antigen (cea) protein level | 146 | $19 | $83 |
| Office visit, established patient, complex (40-54 min) | 99 | $139 | $447 |
| Office visit, established patient (20-29 min) | 76 | $69 | $226 |
| Thyroid stimulating hormone (TSH) test | 74 | $16 | $73 |
| Free thyroxine (T4) test | 73 | $9 | $39 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 68 | $1,162 | $3,581 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 68 | $401 | $982 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 67 | $20 | $89 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 65 | $58 | $238 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $137 | $685 |
| New patient office visit, complex (60-74 min) | 59 | $176 | $638 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $26 | $113 |
| Administration of additional new drug or substance into vein, 1 hour or less | 49 | $50 | $236 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 47 | $52 | $231 |
| CT scan of chest, without contrast | 40 | $38 | $649 |
| Injection of additional new drug or substance into vein | 32 | $11 | $74 |
| New patient office visit (45-59 min) | 24 | $132 | $502 |
| Ct scan of abdomen and pelvis without contrast | 22 | $67 | $426 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 20 | $4 | $15 |
| Initial hospital admission, high complexity | 14 | $142 | $642 |
| Stool analysis for blood, by peroxidase activity | 13 | $4 | $14 |
| Ct scan of chest with contrast | 12 | $47 | $807 |
| CT scan of abdomen and pelvis with contrast | 11 | $133 | $812 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
73.5% medium
25.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,969
Total received (2018-2024)
Avg $2,424/year across 7 years
Top 28% in FL for hematology
82
Companies
1,021
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,392 (90.7%)
Other
Charitable contributions, space rental, and other categories
$1,101 (6.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$477 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$168
2023$3,066
2022$2,834
2021$3,265
2020$1,825
2019$2,964
2018$2,848
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,660
AstraZeneca Pharmaceuticals LP
$1,283
PFIZER INC.
$1,016
Janssen Biotech, Inc.
$921
Lilly USA, LLC
$834
Amgen Inc.
$796
Incyte Corporation
$778
E.R. Squibb & Sons, L.L.C.
$734
Celgene Corporation
$637
GENZYME CORPORATION
$572
Astellas Pharma US Inc
$558
Genentech USA, Inc.
$556
Merck Sharp & Dohme LLC
$426
Merck Sharp & Dohme Corporation
$391
Daiichi Sankyo Inc.
$373
GlaxoSmithKline, LLC.
$338
Seattle Genetics, Inc.
$287
Eisai Inc.
$285
Seagen Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$240
Pacira Pharmaceuticals Incorporated
$232
Bayer HealthCare Pharmaceuticals Inc.
$183
Taiho Oncology, Inc.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
EISAI INC.
$157
Exelixis Inc.
$155
Alexion Pharmaceuticals, Inc.
$142
Ipsen Biopharmaceuticals, Inc
$133
AbbVie Inc.
$119
Regeneron Healthcare Solutions, Inc.
$113
Puma Biotechnology, Inc.
$110
Medtronic USA, Inc.
$108
Adaptive Biotechnologies Corporation
$106
Karyopharm Therapeutics Inc.
$100
PUMA BIOTECHNOLOGY, INC.
$92
AbbVie, Inc.
$89
ARRAY BIOPHARMA INC
$88
Pharmacyclics LLC, An AbbVie Company
$87
Kyowa Kirin, Inc.
$83
ABBVIE INC.
$80
Kite Pharma, Inc.
$79
MEDIVATION FIELD SOLUTIONS LLC
$76
Pharmacosmos Therapeutics Inc.
$74
Dova Pharmaceuticals
$70
TESARO, Inc.
$67
Helsinn Therapeutics (U.S.), Inc.
$64
JAZZ PHARMACEUTICALS INC.
$62
Fennec Pharmaceuticals, Inc.
$60
SOBI, INC
$57
EMD Serono, Inc.
$56
Advanced Accelerator Applications
$48
BeiGene USA, Inc.
$43
Clovis Oncology, Inc.
$43
Gilead Sciences, Inc.
$43
CTI BioPharma Corp.
$39
Foundation Medicine, Inc.
$37
Deciphera Pharmaceuticals Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$36
Pharmacyclics LLC, an AbbVie Company
$35
Sobi, Inc
$34
AVEO Pharmaceuticals, Inc.
$34
Stemline Therapeutics Inc.
$33
MorphoSys, US Inc.
$32
Octapharma USA, Inc.
$29
Global Blood Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
PharmaEssentia USA Corporation
$23
Myriad Genetic Laboratories, Inc.
$20
Mylan Institutional Inc.
$19
Rigel Pharmaceuticals, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Array BioPharma Inc.
$17
Ethicon US, LLC
$17
Fortovia Therapeutics, Inc.
$16
Organon LLC
$16
TG THERAPEUTICS, INC.
$16
Heron Therapeutics, Inc.
$15
Mirati Therapeutics, Inc.
$15
Sun Pharmaceutical Industries Inc.
$13
Agios Pharmaceuticals, Inc.
$13
NanoString Technologies, Inc.
$11
Top 3 companies account for 23.3% of total payments
Associated products mentioned in payments ›
6 · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · EXPAREL · Enhertu · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUMOXITI · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · OXBRYTA · Ogivri · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROSIGNA ASSAY · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SANCUSO · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $71 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tolnai is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tolnai experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Tolnai performed 5,700 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tolnai receive payments from pharmaceutical companies?
Yes. Dr. Tolnai received a total of $16,969 from 82 companies across 1,021 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tolnai's costs compare to other hematologys in Jupiter?
Dr. Tolnai's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tolnai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Jupiter
Browse hematologys in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology